Biotech Chimerix shines in IPO debut as interest grows in antiviral drugs

Ryan McBride Chimerix sped out of the IPO gate on Thursday. The Durham, NC-based drug developer's ($ CMRX) stock soared on its first day of trading, with an initial price of $ ...

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Ryan McBride With pharma groups hunting for external innovation, an analysis shows a spike in early-stage biotech partnerships during the first quarter of 2013. Overall deal volume ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS